Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-012096
Filing Date
2025-05-06
Accepted
2025-05-06 16:05:06
Documents
2
Period of Report
2025-05-02

Document Format Files

Seq Description Document Type Size
1 form4-05062025_040501.html 4  
1 form4-05062025_040501.xml 4 7475
2 ex24-05062025_040501.htm EX-24 4298
  Complete submission text file 0001415889-25-012096.txt   13377
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 401 NEW YORK NY 10036
Business Address
Liu Dongfang (Reporting) CIK: 0001937915 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39351 | Film No.: 25917170